These findings indicate that this in vitro paradigm does recapitulate the main features of insulin resistance at the cellular level, and may represent a valuable tool for the screening of insulin sensitizers and potential disease-modifying drugs in cholinergic neurons, of relevance for therapy of AD and insulin-related brain diseases. The gene discussed is INS; the disease is Alzheimer disease.